US2004175723A1PendingUtilityA1
TaqManTM-PCR for the detection of pathogenic E.coli strains
Priority: Apr 22, 1997Filed: Oct 10, 2003Published: Sep 9, 2004
Est. expiryApr 22, 2017(expired)· nominal 20-yr term from priority
Inventors:Klaus Pfeffer
C12Q 1/6823C12Q 1/689
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for the detection of pathogenic E. coli in a sample comprising PCR amplification of DNA isolated from said sample using oligonucleotide primers specific for pathogenic E. coli.
Claims
exact text as granted — not AI-modified1 . A method for the detection of pathogenic E. coli in a sample comprising PCR amplification of DNA isolated from said sample using a set of oligonucleotide primers specific for virulence factors/toxins of pathogenic E. coli selected from
primers that hybridise to a gene encoding heat labile toxin, or heat stabile toxin for the amplification of a DNA sequence characteristic for enterotoxigenic E. coli; primers that hybridise to a gene encoding heat stabile toxin for the amplification of a DNA sequence characteristic for enteroaggregative E. coli; primers that hybridise to the pCVD432 plasmid for the amplification of a DNA sequence characteristic for enteroaggregative E. coli; primers that hybridise to the inv-plasmid for the amplification of a DNA sequence contained in enteroinvasive E. coli; primers that hybridise to the EAF plasmid, or the eae gene for the amplification of a DNA sequence characteristic for enteropathogenic E. coli ; and/or primers that hybridise to the genes encoding shiga-like toxin sltI or sltII for the amplification of a DNA sequence characteristic for enterohemorrhagic E. coli , followed by detection and identification of the amplified product using conventional methods.
2 . The method according to claim 1 wherein
the set of primers that hybridise to the gene encoding heat labile toxin characteristic for enterotoxigenic E. coli is
LT-1: 5′ GCG TTA CTA TCC TCT CTA TGT G 3′ and LT-2: 5′ AGT TTT CCA TAC TGA TTG CCG C 3′;
the set of primers that hybridise to the gene encoding heat stabile toxin characteristic for enterotoxigenic E. coli is
ST-1: 5′ TCC CTC AGG ATG CTA AAC CAG 3′ and ST-2a: 5′ TCG ATT TAT TCA ACA AAG CAA C 3′;
the set of primers that hybridise for the gene encoding heat stabile toxin characteristic for enteroaggregative E. coli is
EASTI-1: 5′ AAC TGC TGG GTA TGT GGC TGG 3′ and EASTI-2: 5′ TGC TGA CCT GCC TCT TCC ATG 3′;
the set of primers which hybridise to the pCVD432 plasmid is
EA-1: 5′ CTG GCG AAA GAC TGT ATC ATT G 3′ and EA-2: 5′ TAA TGT ATA GAA ATC CGC TGT T 3′;
the set of primers which hybridise to the inv-plasmid is
EI-1: 5′ TTT CTG GAT GGT ATG GTG AGG 3′ and EI-2: 5′ CTT GAA CAT AAG GAA ATA AAC 3′;
the set of primers which hybridise to the EAF plasmid is
EP-1: 5′ CAG GGT AAA AGA AAG ATG ATA AG 3′ and EP-2: 5′ AAT ATG GGG ACC ATG TAT TAT C 3′;
the set of primers which hybridise to the eae gene is
EPeh-1: 5′ CCC GGA CCC GGC ACA AGC ATA AG 3′ and EPeh-2: 5′ AGT CTC GCC AGT ATT CGC CAC C 3′;
the primers which hybridises to the gene encoding shiga-like toxin SltI is
SltI-1: 5′ ATG AAA AAA ACA TTA TTA ATA GC 3′ and SltI-2: 5′ TCA CYG AGC TAT TCT GAG TCA AGC 3′; and
the primers which hybridises to the gene encoding shiga-like toxin SltII is
SltII-1: 5′ ATG AAG AAG ATR WTT RTD GCR GYT TTA TTY G 3′ and SltII-2: 5′ TCA GTC ATW ATT AAA CTK CAC YTS RGC AAA KCC 3′
wherein W is A/T, R is A/G, D is A/G/T, Y is C/T and K is G/T.
3 . The method according to claims 1 to 2 wherein a polymerase having additional 5′-3′ exonuclease activity is used for the amplification of DNA, and an oligonucleotide probe labelled at the most 5′ base with a fluorescent dye and at the most 3′ base with a fluorescent quencher dye which hybridises within the target DNA is included in the amplification process; said labelled oligonucleotide probe being susceptible to 5′-3′ exonuclease degradation by said polymerase to produce fragments that can be detected by fluorogenic detection methods.
4 . The method according to claim 3 wherein
the labelled oligonucleotide probe for the detection of heat labile toxin characteristic for enterotoxigenic E. coli is
5′ AGC TCC CCA CTC TAT TAC AGA ACT ATG 3′ ;
the labelled oligonucleotide probe for the detection of heat stabile toxin characteristic for enterotoxigenic E. coli is
5′ ACA TAC GTT ACA GAC ATA ATC AGA ATC AG 3′ ;
the labelled oligonucleotide probe for the detection of heat stabile toxin characteristic for enteroaggregative E. coli is
5′ ATG AAG GGG CGA AGT TCT GGC TCA ATG TGC 3′ ;
the labelled oligonucleotide probe for the detection of pCVD432 plasmid is
5′ CTC TTT TAA CTT ATG ATA TGT AAT GTC TGG 3′ ;
the labelled oligonucleotide probe for the detection of the inv-plasmid is;
5′ CAA AAA CAG AAG AAC CTA TGT CTA CCT 3′ ;
the labelled oligonucleotide probe for the detection of the EAF-plasmid is;
5′° CTT GGA GTG ATC GAA CGG GAT CCA AAT 3′ ;
the labelled oligonucleotide probe for the detection of the eae gene is
5′ TAA ACG GGT ATT ATC AAC AGA AAA ATC C 3′ ;
the labelled oligonucleotide probe for the detection of shiga-like toxin SltI gene is
5′ TCG CTG AAT CCC CCT CCA TTA TGA CAG GCA 3′ ; and
the labelled oligonucleotide probe for the detection of shiga-like toxin SltII gene is
5′ CAG GTA CTG CAT TTG ATT GTG ACA GTC ATT 3′ .
5 . The method according to claims 3 to 4 wherein the fluorescent reporter dye is 6-carboxy-fluoroscein, tetrachloro-6-carboxy-fluoroscein, or hexachloro-6-carboxy-fluoroscein, and the fluorescent quencher dye is 6-carboxytetramethyl-rhodamine.
6 . The method according to claims 1 to 5 wherein the PCR amplification process consists of 35 PCR cycles at a MgCl 2 concentration of 5.2 mmol, an annealing temperature of 55° C. and an extension temperature of 65° C.
7 . A set of primers useful for PCR amplification of DNA specific for virulence factors/toxins of pathogenic E. coli selected from:
a set of primers that hybridise to a gene encoding heat labile toxin, or heat stabile toxin of enterotoxigenic E. coli; a set of primers that hybridise to a gene encoding heat stabile toxin of enteroaggregative E. coli; a set of primers that hybridise to the pCVD432 plasmid of enteroaggregative E. coli; a set of primers that hybridise to the inv-plasmid of enteroinvasive E. coli; a set of primers that hybridise to the EAF plasmid, or the eae gene of enteropathogenic E. coli; and a set of primers that hybridise to the gene encoding shiga-like toxin sltl or sltII of enterohemorrhagic E. coli,
8 . The set of primers according to claim 7 wherein
the set of primers which hybridise to the gene encoding heat labile toxin of enterotoxigenic E. coli is
LT-1: 5′ GCG TTA CTA TCC TCT CTA TGT G 3 and LT-2: 5′ AGT TTT CCA TAC TGA TTG CCG C 3′;
the set of primers which hybridise to the gene encoding heat stabile toxin of enterotoxigenic E. coli is
ST-1: 5′ TCC CTC AGG ATG CTA AAC CAG 3′ and ST-2a: 5′ TCG ATT TAT TCA ACA AAG CAA C 3′;
the set of primers which hybridise to the gene encoding heat stabile toxin of enteroaggregative E. coli is
EASTI-1: 5′ AAC TGC TGG GTA TGT GGC TGG 3′ and EASTI-2: 5′ TGC TGA CCT GCC TCT TCC ATG 3′;
the set of primers which hybridise to the pCVD432 plasmid is
EA-1: 5′ CTG GCG AAA GAC TGT ATC ATT G 3′ and EA-2: 5′ TAA TGT ATA GAA ATC CGC TGT T 3′;
the set of primers which hybridise to the inv-plasmid is
EI-1: 5′ TTT CTG GAT GGT ATG GTG AGG 3′ and EI-2: 5′ CTT GAA CAT AAG GAA ATA AAC 3′;
the set of primers which hybridise to the EAF plasmid is
EP-1: 5′ CAG GGT AAA AGA AAG ATG ATA AG 3′ and EP-2: 5′ AAT ATG GGG ACC ATG TAT TAT 3′;
the set of primers which hybridise to the eae gene is
EPeh-1: 5′ CCC GGA CCC GGC ACA AGC ATA AG 3′ and EPeh-2: 5′ AGT CTC GCC AGT ATT CGC CAC C 3′;
the set of primers which hybridise to the shiga-like toxin sltI gene is
SltI-1: 5′ ATG AAA AAA ACA TTA TTA ATA GC 3′ and SltI-2: 5′ TCA CYG AGC TAT TCT GAG TCA AGC 3′;
and
the set of primers which hybridise to the shiga-like toxin sltII is
SltII-1: 5′ ATG AAG AAG ATR WTT RTD GCR GYT TTA TTY G 3′ and SltII-2: 5′ TCA GTC ATW ATT AAA CTK CAC YTS RGC AAA KCC 3′
wherein W is A/T, R is A/G, D is A/G/T, Y is C/T and K is G/T.
9 . The set of primers according to claim 8 which in addition to the primers for amplification of target DNA comprise a labelled oligonucleotide probe which is labelled with a fluoroscent reporter dye, such as 6-carboxy-fluoroscein, tetrachloro-6-carboxy-fluoroscein, hexachloro-6-carboxy-fluoroscein, at the most 5′ base and a fluoroscent quencher dye, such as 6-carboxytetramethyl-rhodamine, at the most 3′ base, and have a nucleotide sequence selected from
5′ AGC TCC CCA GTC TAT TAC AGA ACT ATG 3′
which hybridises to a gene encoding heat labile toxin of enterotoxigenic E. coli;
5′ ACA TAC GTT ACA GAC ATA ATC AGA ATC AG 3′
which hybridises to a gene encoding heat stabile toxin of enterotoxigenic E. coli;
5′ ATG AAG GGG CGA AGT TCT GGC TCA ATG TGC 3′
which hybridises to a gene encoding heat stabile toxin of enteroaggregative E. coli;
5′ CTC TTT TAA CTT ATG ATA TGT AAT GTC TGG 3′
which hybridises to the pCVD432 plasmid;
5′ CAA AAA CAG AAG AAC CTA TGT CTA CCT 3′
which hybridises to the inv-plasmid;
5′ CTT GGA GTG ATC GAA CGG GAT CCA AAT 3′
which hybridises to the EAF plasmid;
5′ TAA ACG GGT ATT ATC AAC AGA AAA ATCC 3′
which hybridises to the eae gene;
5′ TCG CTG AAT CCC CCT CCA TTA TGA CAG GCA 3′
which hybridises to the shiga-like toxin SltI gene; and
5′ CAG GTA CTG GAT TTG ATT GTG ACA GTC ATT 3′
which hybridises to the shiga-like toxin SltII gene.
10 . The use of the method according to claims 1 to 6 for diagnosing an E. coli infection of a living animal body, including a human, or for the detection of E. coli contamination of consumables, such as meat, milk and vegetables.Join the waitlist — get patent alerts
Track US2004175723A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.